AllianceBernstein
TECX

AllianceBernstein’s Tectonic Therapeutic TECX Stock Holding History

AllianceBernstein’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,525
Closed -$40K – 3403
2022
Q1 		$40K Sell
2,525
-233
-8% -$4.82K ﹤0.01% 3190
2021
Q4 		$127K Sell
2,758
-209
-7% -$12K ﹤0.01% 3162
2021
Q3 		$199K Hold
2,967
– – ﹤0.01% 3092
2021
Q2 		$316K Buy
2,967
+600
+25% +$71.1K ﹤0.01% 2988
2021
Q1 		$360K Hold
2,367
– – ﹤0.01% 2829
2020
Q4 		$396K Hold
2,367
– – ﹤0.01% 2704
2020
Q3 		$370K Sell
2,367
-133
-5% -$26.8K ﹤0.01% 2693
2020
Q2 		$524K Buy
2,500
+133
+6% +$27.4K ﹤0.01% 2579
2020
Q1 		$442K Hold
2,367
– – ﹤0.01% 2414
2019
Q4 		$572K Hold
2,367
– – ﹤0.01% 2490
2019
Q3 		$401K Buy
2,367
+1,067
+82% +$242K ﹤0.01% 2668
2019
Q2 		$254K Buy
1,300
+433
+50% +$93.4K ﹤0.01% 2885
2019
Q1 		$229K Buy
+867
New +$158K ﹤0.01% 2866

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein's TECX Position: Q2 2022 in Review

AllianceBernstein sold out of Tectonic Therapeutic (TECX) in Q2 2022, closing a stake of 2,525 shares — an estimated $40K sold.

AllianceBernstein first reported a position in TECX in Q1 2019 and held it in 13 quarters. The position peaked at $572K in Q4 2019. 64 funds tracked by Wall St. Rank hold TECX as of Q2 2022.

  • AllianceBernstein reported no remaining Tectonic Therapeutic position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 2,525 Tectonic Therapeutic shares in Q2 2022, an estimated $40K.
  • AllianceBernstein first reported a position in Tectonic Therapeutic in Q1 2019 and held it in 13 quarters.
  • AllianceBernstein's Tectonic Therapeutic position peaked at $572K in Q4 2019.
  • 64 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.